foxo4 dri peptide senolytic 2023 2024 study

foxo4 dri peptide senolytic 2023 2024 study foxo4-dri mouse Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI Senolytics: from pharmacological inhibitors to

Name: foxo4 dri peptide senolytic 2023 2024 study foxo4-dri mouse Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI Senolytics: from pharmacological inhibitors to
Brand: centoria.fr
SKU: 18209778774
Price: 25.80 USD
Availability: InStock
Rating: 4.2844 (9 reviews)

Senolytics: from pharmacological inhibitors to immunotherapies, a promising future for patients' treatment npj Aging Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI FOXO4 p53 Peptide Peptagon FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC

SKU: 18209778774 · From centoria.fr

4.3

USD25.80 USD49.80

Pay in 4 interest-free payments of $6.45 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

increases gluconeogenesis, glycogenolysis, lipolysis, and ketogenesis

Temperature 20C or below Long-term storage Light Protected Avoid UV exposure Form Lyophilized Until lab use Disclaimer Research Use Only All products are intended strictly for laboratory research purposes and are not for human consumption